This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Marc Schoenhentz
Introduction
Marc Schoenhentz is a notable inventor based in Ungersheim, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotics. His work has implications for therapeutic applications and showcases the importance of innovation in medicine.
Latest Patents
Schoenhentz holds a patent for "Salts and solid forms of a monobactam antibiotic." This invention provides new solid forms, salts, and polymorphs of a specific compound, referred to as Compound X. The patent outlines pharmaceutical compositions containing these forms and processes for their manufacture and therapeutic use.
Career Highlights
Marc Schoenhentz is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in the pharmaceutical industry. His contributions are vital in advancing antibiotic therapies and improving patient outcomes.
Collaborations
Schoenhentz has collaborated with notable colleagues, including Eric Aubin and Anthony Casarez. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical innovations.
Conclusion
Marc Schoenhentz's work exemplifies the critical role of inventors in advancing medical science. His patent on monobactam antibiotics highlights the ongoing need for innovation in healthcare. Through his contributions, he continues to impact the pharmaceutical landscape positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile